14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival

Por Neal, Christopher L., Yao, Jun, Yang, Wentao, Zhou, Xiaoyan, Nguyen, Nina T., Lu, Jing, Danes, Christopher G., Guo, Hua, Lan, Keng-Hsueh, Ensor, Joe, Hittelman, Walter, Hung, Mien-Chie, Yu, Dihua
Publicado em 2009

Functional Significance of VEGFR-2 on Ovarian Cancer Cells

Por Spannuth, Whitney A., Nick, Alpa M., Jennings, Nicholas B., Armaiz-Pena, Guillermo N., Mangala, Lingegowda S., Danes, Christopher G., Lin, Yvonne G., Merritt, William M., Thaker, Premal H., Kamat, Aparna A., Han, Liz Y., Tonra, James R., Coleman, Robert L., Ellis, Lee M., Sood, Anil K.
Publicado em 2009

Dual targeting of EphA2 and FAK in ovarian carcinoma

Por Shahzad, Mian M.K., Lu, Chunhua, Lee, Jeong-Won, Stone, Rebecca L., Mitra, Rahul, Mangala, Lingegowda S., Lu, Yiling, Baggerly, Keith A., Danes, Christopher G., Nick, Alpa M., Halder, Jyotsnabaran, Kim, Hye-Sun, Vivas-Mejia, Pablo, Landen, Charles N., Lopez-Berestein, Gabriel, Coleman, Robert L., Sood, Anil K.
Publicado em 2009

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

Por Merritt, William M., Danes, Christopher G., Shahzad, Mian M.K., Lin, Yvonne G., Kamat, Aparna A., Han, Liz Y., Spannuth, Whitney A., Nick, Alpa M., Mangala, Lingegowda S., Stone, Rebecca L., Kim, Hye Sun, Gershenson, David M., Jaffe, Robert B., Coleman, Robert L., Chandra, Joya, Sood, Anil K.
Publicado em 2009

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Por Mangala, Lingegowda S., Zuzel, Vesna, Schmandt, Rosemarie, Leshane, Erik S., Halder, Jyotsna B., Armaiz-Pena, Guillermo N., Spannuth, Whitney A., Tanaka, Takemi, Shahzad, Mian M.K., Lin, Yvonne G., Nick, Alpa M., Danes, Christopher G., Lee, Jeong-Won, Jennings, Nicholas B., Vivas-Mejia, Pablo E., Wolf, Judith K., Coleman, Robert L., Siddik, Zahid H., Lopez-Berestein, Gabriel, Lutsenko, Svetlana, Sood, Anil K.
Publicado em 2009